Terminated PHASE2 INTERVENTIONAL 2-arm NCT00845845

Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)

Sponsor: University of Illinois at Chicago

Conditions Hepatic Steatosis Nonalcoholic Steatohepatitis (NASH)

Interventions Omega-3-acid ethyl esters (Lovaza) Placebo

Updated 7 times since 2017 Last updated: Jun 18, 2013 Started: Mar 31, 2006 Primary completion: Oct 31, 2010 Completion: Oct 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated due to low enrollment.

Other terminated trials from University of Illinois at Chicago

See all terminations from University of Illinois at Chicago

Other Hepatic Steatosis trials with similar outcome

NCT03027700 · Phase NA · Dec 2018

Browse all Hepatic Steatosis trials

A PHASE2 clinical study on Hepatic Steatosis and Nonalcoholic Steatohepatitis (NASH), this trial is terminated or withdrawn. The trial is conducted by University of Illinois at Chicago and has accumulated 7 data snapshots since 2006. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Illinois at Chicago

Data source: University of Illinois at Chicago

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chicago, United States